Eli Lilly’s stock falls after fake blue-check tweet

November 13, 2022

Eli Lilly’s stock fell millions in a single day to $14 billion, all thanks to a fake “verified” account on Elon Musk’s new Twitter payment system.

That account impersonated Eli Lilly and tweeted “insulin is free now,” implying that the pharmaceutical company’s insulin would soon be free.

Other Health care stocks such as Novo Nordisk and Sanofi also came under pressure on Friday, with Novo Nordisk shares falling 3.5% to 111.47 and Sanofi’s losing 3.4% to finish the regular session at 42.80, possibly in solidarity with Eli Lilly.

Although the account was quickly suspended, the damage had already been done, as worried shareholders confused it with reality and sold shares at a rapid pace.

Twitter’s disinformation problem is exacerbated by the democratization of the Blue Check, which has since been halted. Several corporate and government imposters targeted Eli Lilly and Company, including fake accounts for defense manufacturer Lockheed Martin, oil company BP, and produce distributor Chiquita.

The sources for this piece include an article in Investors.com.

Top Stories

Related Articles

January 16, 2026 OpenAI could run out of money within the next 18 months. That prediction, issued by Sebastian Mallaby, more...

January 15, 2026 After a year of growing protests over power bills, water use and unmet job promises, Microsoft on more...

January 14, 2026 Anthropic says that more than 90 per cent of the software powering new versions of Claude is more...

January 14, 2026 Anthropic is pushing deeper into healthcare with a new suite of AI tools aimed at doctors, insurers more...

Jim Love

Jim is an author and podcast host with over 40 years in technology.

Share:
Facebook
Twitter
LinkedIn